Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Login
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

90 articles published Follow:
How CapeStart Accelerated a Regulatory Submissions Through GenAI-Enabled Literature Review

How CapeStart Accelerated a Regulatory Submissions Through GenAI-Enabled Literature Review

Case StudyNovember 15, 2024260Views0Likes0Comments
A leading biotech company, faced critical challenges in their regulatory submission process. They needed to conduct a comprehensive clinical literature review and create a Clinical Evaluation Report (CER) with limited time and resources. The biotech company turned to CapeStart, who provided a hybrid approach combining expert analysis with their GenAI-powered MadeAi™ platform for literature review. Check-out…

Read More

CapeStart's Literature Review Research Report

CapeStart’s Literature Review Research Report

Case StudyNovember 1, 2024592Views0Likes0Comments
CapeStart's Literature Review Research Report examines how life sciences professionals approach literature reviews, exploring their methodologies, challenges, and resource allocation between internal and external teams. The study investigates key aspects including goals, scope, complexity management, and success metrics, while also analyzing information sources and professional associations, along with demographic data from survey respondents.

Read More

CapeStart's Life Science AI Research Report

CapeStart’s Life Science AI Research Report

Case StudyOctober 25, 2024278Views0Likes0Comments
CapeStart's Life Sciences AI Research Report investigates how professionals in the life sciences sector view and utilize artificial intelligence technologies in their work. The study explores current AI implementations and capabilities, while examining organizational goals and targeted impact areas for AI integration. The report analyzes key challenges and obstacles teams face in AI adoption, along…

Read More

Developing an AI Classifier to Support Oncology Decision-Making

Developing an AI Classifier to Support Oncology Decision-Making

Case StudyOctober 8, 2024120Views0Likes0Comments
CapeStart helped a major multinational digital health company develop a multi-omic, AI-powered classifier to predict patient responses to checkpoint inhibitors. Checkpoint inhibitors are a class of immuno-oncology agents often used to treat solid tumors. The client needed a reliable, knowledgeable, experienced and affordable partner to analyze and label a large batch of de-identified multislice CT images.…

Read More

Pharma Manufacturing

How AI is Reshaping Pharmaceutical Manufacturing

BlogSeptember 30, 2024113Views0Likes0Comments
Artificial intelligence (AI) has significantly impacted the pharmaceutical business in several ways, from drug discovery and formulation to clinical trials and monitoring for adverse drug reactions. But AI can also help improve pharma manufacturing, distribution, and supply chain management by improving efficiency, safety, quality, and other processes. Here’s how AI can be used to improve…

Read More